Goldman Sachs Group Inc Annexon, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,317,011 shares of ANNX stock, worth $3.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,317,011
Previous 1,904,378 30.84%
Holding current value
$3.73 Million
Previous $11.3 Million 40.07%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$4.44 - $7.63 $2.61 Million - $4.48 Million
-587,367 Reduced 30.84%
1,317,011 $6.76 Million
Q3 2024

Nov 14, 2024
BUY
$4.49 - $7.2 $5.87 Million - $9.42 Million
1,308,187 Added 219.42%
1,904,378 $11.3 Million
Q2 2024

Aug 13, 2024
BUY
$4.33 - $6.79 $143,864 - $225,597
33,225 Added 5.9%
596,191 $2.92 Million
Q1 2024

May 15, 2024
BUY
$4.03 - $7.81 $1.12 Million - $2.17 Million
278,033 Added 97.58%
562,966 $4.04 Million
Q4 2023

Feb 13, 2024
BUY
$1.63 - $4.63 $64,018 - $181,843
39,275 Added 15.99%
284,933 $1.29 Million
Q3 2023

May 14, 2024
SELL
$2.13 - $3.84 $83,655 - $150,816
-39,275 Reduced 13.78%
245,658 $579,000
Q3 2023

Nov 14, 2023
BUY
$2.13 - $3.84 $337,076 - $607,687
158,252 Added 181.05%
245,658 $579,000
Q2 2023

May 14, 2024
SELL
$2.1 - $6.37 $522,291 - $1.58 Million
-248,710 Reduced 74.0%
87,406 $307,000
Q2 2023

Aug 14, 2023
SELL
$2.1 - $6.37 $522,291 - $1.58 Million
-248,710 Reduced 74.0%
87,406 $307,000
Q1 2023

May 14, 2024
BUY
$3.74 - $7.46 $1.06 Million - $2.11 Million
282,238 Added 523.85%
336,116 $1.29 Million
Q1 2023

May 11, 2023
BUY
$3.74 - $7.46 $1.06 Million - $2.11 Million
282,238 Added 523.85%
336,116 $1.29 Million
Q4 2022

May 14, 2024
SELL
$4.56 - $6.61 $71,578 - $103,757
-15,697 Reduced 22.56%
53,878 $278,000
Q4 2022

Feb 13, 2023
SELL
$4.56 - $6.61 $71,578 - $103,757
-15,697 Reduced 22.56%
53,878 $278,000
Q3 2022

May 14, 2024
SELL
$3.75 - $6.63 $29,662 - $52,443
-7,910 Reduced 10.21%
69,575 $430,000
Q3 2022

Nov 10, 2022
SELL
$3.75 - $6.63 $29,662 - $52,443
-7,910 Reduced 10.21%
69,575 $0
Q2 2022

May 14, 2024
SELL
$2.11 - $4.06 $437,715 - $842,238
-207,448 Reduced 72.81%
77,485 $292,000
Q2 2022

Aug 15, 2022
SELL
$2.11 - $4.06 $528,588 - $1.02 Million
-250,516 Reduced 76.38%
77,485 $292,000
Q1 2022

May 16, 2022
BUY
$2.73 - $11.94 $451,367 - $1.97 Million
165,336 Added 101.64%
328,001 $896,000
Q4 2021

Feb 14, 2022
BUY
$11.49 - $22.0 $1.5 Million - $2.88 Million
130,891 Added 411.94%
162,665 $1.87 Million
Q3 2021

Nov 10, 2021
BUY
$16.35 - $23.4 $519,504 - $743,511
31,774 New
31,774 $591,000

Others Institutions Holding ANNX

# of Institutions
156
Shares Held
98.2M
Call Options Held
146K
Put Options Held
174K
View Full List

About Annexon, Inc.

ANNX Quotes by TradingView
  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $135M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email